Highlights Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Delayed OTC Markets Other stock markets 14:37:55 2024-05-29 EDT			5-day change	1st Jan Change
0.08 ^USD	-26.61%		-26.61%	-47.88%

05-14	Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Highlights

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-14	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Guided Therapeutics Announces Completion of Clinical Study for Chinese Regulatory Approval	11-20	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-10	CI
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-30	CI
Guided Therapeutics Signs Agreement to Begin Clinical Trial for US FDA Approval	22-12-21	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Guided Therapeutics Provides Update of Significant Progress in Chinese Clinical Study for Marketing Approval of the LuViva Advanced Cervical Scan	22-11-09	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-15	CI
Guided Therapeutics, Inc. Receives Institutional Review Board Approval to Start Clinical Study for FDA Approval of the LuViva® Advanced Cervical Scan	22-07-20	CI
Guided Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Guided Therapeutics, Inc. Announces Testing Completion of First 150 Patients in Chinese Clinical Study and Receives Milestone Payment of $177,740	22-03-31	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-30	CI
Guided Therapeutics, Inc. Announces Start of Chinese Clinical Trial for Approval to Market and Sell LuViva in China	21-11-17	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Guided Therapeutics Receives Notification of Successful Clinical Trial Regulatory Review and $133,000 Payment from China	21-08-19	CI
Guided Therapeutics, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-18	CI
Guided Therapeutics Receives News from Chinese State Food and Drug Administration that LuViva Meets Product Technical Requirements	21-07-20	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Guided Therapeutics, Inc.

Equities

GTHP

US40171F5017

Highlights

Filters